FDA Inspection 1266777 — Foresee Pharmaceuticals Co., Ltd
The FDA completed an inspection of Foresee Pharmaceuticals Co., Ltd on Apr 4, 2025 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newark, DE (United States)
Additional details
Sponsor, Contract Research Organization